doi:10.3969/j.issn.1673-8640.2025.08.017

Abstract

CLC Number:

R378.1

Figures/Tables 2

References 17

[1]	UNEMO M, DEL RIO C, SHAFER W M. Antimicrobial resistance expressed by Neisseria gonorrhoeae:a major global public health problem in the 21st century[J]. Microbiol Spectr, 2016, 4(3):10.
[2]	NAKAYAMA S, SHIMUTA K, FURUBAYASHI K, et al. New ceftriaxone- and multidrug-resistant Neisseria gonorrhoeae strain with a novel mosaic penA gene isolated in Japan[J]. Antimicrob Agents Chemother, 2016, 60(7):4339-4341.
[3]	GUERRERO-TORRES M D, MENÉNDEZ M B, GUERRAS C S, et al. Epidemiology,molecular characterisation and antimicrobial susceptibility of Neisseria gonorrhoeae isolates in Madrid,Spain,in 2016[J]. Epidemiol Infect, 2019,147:e274.
[4]	TREMBIZKI E, WAND H, DONOVAN B, et al. The molecular epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in Australia:a nationwide cross-sectional study,2012[J]. Clin Infect Dis, 2016, 63(12):1591-1598.
[5]	Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. M100,CLSI, 2025.
[6]	TAMURA K, STECHER G, KUMAR S. MEGA11:molecular evolutionary genetics analysis version 11[J]. Mol Biol Evol, 2021, 38(7):3022-3027.
[7]	XIE J, CHEN Y, CAI G, et al. Tree Visualization By One Table(tvBOT):a web application for visualizing,modifying and annotating phylogenetic trees[J]. Nucleic Acids Res, 2023, 51(1):W587-W592.
[8]	LIN X, QIN X, WU X, et al. Markedly increasing antibiotic resistance and dual treatment of Neisseria gonorrhoeae isolates in Guangdong,China,from 2013 to 2020[J]. Antimicrob Agents Chemother, 2022, 66(4):e0229421.
[9]	UNEMO M, LAHRA M M, ESCHER M, et al. WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18:a retrospective observational study[J]. Lancet Microbe, 2021, 2(11):e627-e636.
[10]	World Health Organization. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae[EB/OL].(2012-05-04)[2024-08-14]. https://www.who.int/publications/i/item/9789241503501.
[11]	MLYNARCZYK-BONIKOWSKA B, SERWIN A B, GOLPARIAN D, et al. Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland,2010-2012[J]. BMC Infect Dis, 2014,14:65.
[12]	朱邦勇, 李伟, 甘泉, 等. 广西地区淋病患者淋病奈瑟菌对七种抗生素的耐药监测[J]. 中国皮肤性病学杂志, 2018, 32(9):1052-1056.
[13]	MŁYNARCZYK-BONIKOWSKA B, MAJEWSKA A, MALEJCZYK M, et al. Multiresistant Neisseria gonorrhoeae:a new threat in second decade of the XXI century[J]. Med Microbiol Immunol, 2020, 209(2):95-108.
[14]	CHEN S C, YIN Y P, DAI X Q, et al. First nationwide study regarding ceftriaxone resistance and molecular epidemiology of Neisseria gonorrhoeae in China[J]. J Antimicrob Chemother, 2016, 71(1):92-99.
[15]	QIN X, ZHAO Y, CHEN W, et al. Changing antimicrobial susceptibility and molecular characterisation of Neisseria gonorrhoeae isolates in Guangdong,China:in a background of rapidly rising epidemic[J]. Int J Antimicrob Agents, 2019, 54(6):757-765.
[16]	陆善词, 梁栋, 梁连辉, 等. 中山地区淋球菌头孢菌素敏感性及NG-MAST研究[J]. 中国麻风皮肤病杂志, 2021, 37(8):515-518.
[17]	THOMAS J C 4th, JOSEPH S J, CARTEE J C, et al. Phylogenomic analysis reveals persistence of gonococcal strains with reduced-susceptibility to extended-spectrum cephalosporins and mosaic penA-34[J]. Nat Commun, 2021, 12(1):3801.

药物名称	敏感/[株（%）]	中介/[株（%）]	耐药/[株（%）]	MIC范围/（mg·L^-1）	MIC₅₀/（mg·L^-1）	MIC₉₀/（mg·L^-1）
青霉素	2（2）	25（28）	62（70）	0.06~>32.00	>32.00	>32.00
四环素	3（3）	16（18）	70（79）	0.25~>32.00	32.00	>32.00
环丙沙星			89（100）	2~32	16	16
大观霉素	89（100）			2~16	16	16
头孢曲松	89（100）			0.002~0.060	0.015	0.030
头孢克肟	86（96）			0.008~1.000	0.125	0.250

药物名称	敏感/[株（%）]	中介/[株（%）]	耐药/[株（%）]	MIC范围/（mg·L^-1）	MIC₅₀/（mg·L^-1）	MIC₉₀/（mg·L^-1）
青霉素	2（2）	25（28）	62（70）	0.06~>32.00	>32.00	>32.00
四环素	3（3）	16（18）	70（79）	0.25~>32.00	32.00	>32.00
环丙沙星			89（100）	2~32	16	16
大观霉素	89（100）			2~16	16	16
头孢曲松	89（100）			0.002~0.060	0.015	0.030
头孢克肟	86（96）			0.008~1.000	0.125	0.250

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 2

References 17

Related Articles 15

Recommended Articles

Metrics

[1]	SUN Gang, SUN Hui, BAO Lina, LIU Xianwei, LU Mingyang, LIU Jing, TIAN Yuan. Drug resistance and molecular epidemiology of OS-MRSA in Hulunbuir，Inner Mongolia [J]. Laboratory Medicine, 2025, 40(6): 551-554.
[2]	YAO Ling, GAO Chunyan, LIU Minglei. Virulence characteristics of Streptococcus pneumoniae，PBP gene mutation and β-lactam resistance [J]. Laboratory Medicine, 2025, 40(5): 450-454.
[3]	ZHOU Ning, MAO Min, JI Xin, HE Jiale, YE Xiuyun, LIN Yubo, ZHONG Wei, LIU Yang. Etiology and molecular analysis of Streptococcus suis type 14 causing sepsis, meningitis and pneumonia [J]. Laboratory Medicine, 2024, 39(11): 1042-1047.
[4]	. [J]. Laboratory Medicine, 2024, 39(11): 1122-1127.
[5]	QIN Zehui, CHEN Qiuyu, LIANG Fengrui, SONG Yuqi, YE Liping, LIU Xiangtian, TIAN Xinghan. Construction of prognostic decision tree model of Staphylococcus aureus bloodstream infection in intensive care unit based on MIMIC-Ⅳ database data [J]. Laboratory Medicine, 2024, 39(10): 999-1004.
[6]	. [J]. Laboratory Medicine, 2024, 39(6): 592-597.
[7]	ZHAO Yanan, XIAO Weili, CAO Qixin, YAN Yan, CUI Xiuge, ZHAO Jianping. Relation of drug resistance，serotypes and genotypes of Group B Streptococcus in perinatal pregnant females and pregnancy outcomes [J]. Laboratory Medicine, 2024, 39(4): 382-386.
[8]	CHEN Huan, DONG Fang, LÜ Zhiyong, ZHEN Jinghui, CHEN Mei, SU Jianrong. Serotypes and drug resistance of invasive Streptococcus agalactiae in children [J]. Laboratory Medicine, 2024, 39(3): 260-264.
[9]	MA Chen, ZHANG Yi, LI Fang, WANG Jing, CHEN Wei. Clinical characteristics，drug resistance and poor prognosis factors in children with invasive pneumococcal disease with necrotizing pneumonia [J]. Laboratory Medicine, 2024, 39(3): 265-271.
[10]	TAN Haiyan, JIANG Yurong. Role of Group B Streptococcus detection in pregnant women combined with fetal cord blood neutrophil CD64 index for predicting neonatal infection with premature rupture of membranes [J]. Laboratory Medicine, 2024, 39(1): 53-59.
[11]	TIAN Yuanyuan, JIA Xiongfei. Advantages and pathogenicity of Enterococci [J]. Laboratory Medicine, 2023, 38(11): 1101-1105.
[12]	KANG Yi, ZHU Hong, SHEN Han, ZHOU Wanqing. Virulence gene analysis of Enterococcus isolated from clinical blood and urine samples [J]. Laboratory Medicine, 2022, 37(11): 1030-1033.
[13]	SUN Gang, SUN Hui, DU Yandan, LI Yinyan, LI Yingzhi, DONG Zhanzhu, TONG Lijun, PENG Bo. Study on the drug resistance and molecular epidemiological characteristics of MRSA in Hulunbuir [J]. Laboratory Medicine, 2021, 36(6): 600-603.
[14]	. [J]. Laboratory Medicine, 2020, 35(1): 37-40.
[15]	MA Bing, WANG Fangfang, WANG Shanmei, ZHANG Jiangfeng, YAN Wenjuan, JING Nan, LI Yi. Performance comparison of 4 panels for in vitro drug susceptibility test of Streptococcus pneumoniae [J]. Laboratory Medicine, 2019, 34(6): 547-550.